Cholangiocarcinoma cells express robust amounts of antiapoptotic Bcl-2 family proteins, in particular Mcl-1, which mitigates TRAIL cytotoxicity [14], [15], consistent with a mitochondria-dependent, Type II death receptor signal. Here, BCL2 is linked to cholangiocarcinoma.